Jpmorgan Chase & CO Pulmonx Corp Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LUNG
# of Institutions
123Shares Held
31MCall Options Held
300Put Options Held
204K-
Primecap Management CO Pasadena, CA5.68MShares$36 Million0.04% of portfolio
-
Morgan Stanley New York, NY3.79MShares$24 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$16.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$14.4 Million0.0% of portfolio
-
Jefferies Group LLC New York, NY1.2MShares$7.62 Million0.2% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $236M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...